Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 44, 2016 - Issue 1
Submit an article Journal homepage
1,505
Views
19
CrossRef citations to date
0
Altmetric
Article

Preparation of budesonide nanosuspensions for pulmonary delivery: Characterization, in vitro release and in vivo lung distribution studies

Yuan ZhangDepartment of Pediatrics of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P. R. China
&
Jianhua ZhangDepartment of Pediatrics of Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, P. R. ChinaCorrespondence[email protected]
Pages 285-289 | Received 17 Jun 2014, Accepted 10 Jul 2014, Published online: 06 Aug 2014

References

  • Barnes PJ. 2007. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. BMJ. 335:513.
  • Brightling CE, Desai D. 2013. Reply: role of primary necrosis/lysis of submucosal eosinophils in obese individuals with asthma. Am J Respir Crit Care Med. 188:1468–1469.
  • Carr WW. 2013. New therapeutic options for allergic rhinitis: back to the future with intranasal corticosteroid aerosols. Am J Rhinol Allergy. 27:309–313.
  • Chavhan SS, Petkar KC, Sawant KK. 2011. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. Crit Rev Ther Drug Carrier Syst. 28:447–488.
  • Daheb K, Lecours JP, Lipman ML, Hildgen P, Roy JJ. 2013. Prediction of in vivo atenolol removal by high-permeability hemodialysis based on an in vitro model. J Pharm Pharm Sci. 16:657–664.
  • Dyer MJ, Halpin DM, Stein K. 2006. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract. 7:34.
  • Higuchi WI. 1962. The analysis of data on the medicament release from ointments. J Pharm Sci. 51:802–804.
  • Kesisoglou F, Mitra A. 2012. Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds. AAPS J. 14:677–687.
  • Kroegel C. 2009. Global Initiative for Asthma (GINA) guidelines: 15 years of application. Expert Rev Clin Immunol. 5:239–249.
  • Liu Y, Xie P, Zhang D, Zhang Q. 2012. A mini review of nanosuspensions development. J Drug Target. 20:209–223.
  • Lobo JM, Schiavone H, Palakodaty S, York P, Clark A, Tzannis ST. 2005. SCF-engineered powders for delivery of budesonide from passive DPI devices. J Pharm Sci. 94:2276–2288.
  • Olaguibel JM, Quirce S, Juliá B, Fernández C, Fortuna AM, Molina J, et al. 2012. Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res. 13:50.
  • Persson C.Primary lysis of eosinophils in severe desquamative asthma. Clin Exp Allergy. 2014; 44:173–183.
  • Postma DS, Kerstjens HA, ten Hacken NH. 2008. Inhaled corticosteroids and long-acting beta-agonists in adult asthma: a winning combination in all? Naunyn Schmiedebergs Arch Pharmacol. 378:203–215.
  • Rasenack N, Steckel H, Müller BW. 2003. Micronization ofanti- inflammatory drugs for pulmonary delivery by a controlled crystallization process. J Pharm Sci. 92:35–44.
  • Spangler M, Hawley H, Barnes N, Saxena S. 2013. A review of guidelines and pharmacologic options for asthma treatment, with a focus on exercise-induced bronchoconstriction. Phys Sportsmed. 41:50–57.
  • Xie M, Wenzel SE. 2013. A global perspective in asthma: from phenotype to endotype. Chin Med J (Engl). 126:166–174.
  • Velaga SP, Berger R, Carlfors J. 2002. Supercritical fluids crystallization of budesonide and flunisolide. Pharm Res. 19:1564–1571.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.